Top Biotechnology & Medical Research stocks in North America
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
VRTXVertex Pharmaceuticals | $116.14bn | 28.79 | n/a |
REGNRegeneron Pharmaceuticals | $81.10bn | 17.56 | n/a |
SGENSeagen | $43.15bn | n/a | n/a |
IQVIqvia Holdings | $36.63bn | 25.16 | n/a |
BNTXBioNTech SE | $27.12bn | n/a | n/a |
ICLRIcon | $17.69bn | 21.94 | n/a |
UTHRUnited Therapeutics | $16.65bn | 15.62 | n/a |
MRNAModerna | $15.82bn | n/a | n/a |
SMMTSummit Therapeutics | $14.01bn | n/a | n/a |
INSMInsmed | $13.09bn | n/a | n/a |
NBIXNeurocrine Biosciences | $12.72bn | 33.02 | n/a |
KRTXKaruna Therapeutics | $12.58bn | n/a | n/a |
TECHBIO-TECHNE | $11.33bn | 55.69 | 0.45% |
PCVXVaxcyte | $11.04bn | n/a | n/a |
SRPTSarepta Therapeutics | $10.91bn | 92.74 | n/a |
MEDPMedpace Holdings | $10.47bn | 29.58 | n/a |
EXELExelixis | $10.17bn | 19.92 | n/a |
CRLCharles River Laboratories International | $10.01bn | 21.06 | n/a |
EXASExact Sciences | $9.79bn | n/a | n/a |
RXDXPrometheus Biosciences | $9.56bn | n/a | n/a |